Drug facts
MoleculeAtorvastatin (Lipitor)
Generics already compete: 21 makers on the market. 92 A-rated products from 21 makers substitute at the counter.
Lipitor was first approved by the FDA on 12/17/1996 under NDA 020702; the application holder is Upjohn Manufacturing Ireland Unltd.
The latest NADAC for ATORVASTATIN 20 MG TABLET is $0.03 per unit (as of 10/28/2026).
Holder Upjohn Manufacturing Ireland UnltdApplication NDA 020702Approved 12/17/1996
01Patents and exclusivity
When competition can legally begin. A generic can launch once both exclusivity and the last listed patent expire, unless a court or settlement says otherwise.
- Latest patent
- No Lipitor patent listed in the Orange Book Orange Book
- Later patents, other products
- Atorvaliq 06/07/2037 Orange Book
02Competition
- Generics
- 21 generic makers Orange Book
- First generic approved
- 11/30/2011 Orange Book
Every listingEach listing and maker behind the generics count.
Price erosionHow NADAC moves as generics enter.
PrescribersWho prescribes it, from Medicare data.
Available in the full Atorvastatin profile.See what is included
03Supply and price
- FDA drug shortage
- ClearNot on the current shortage list FDA shortages
- NADAC
- $0.03 per unitATORVASTATIN 20 MG TABLET, mid-priced of 4 strengths, as of 10/28/2026 CMS NADAC
- Latest recall
- 09/19/2025Class II, Atorvastatin Calcium, Ascend Laboratories, LLC FDA enforcement
04Product
- Application holder
- Upjohn Manufacturing Ireland Unltd Orange Book
- Application
- NDA 020702 Orange Book
- First approved
- 12/17/1996 Orange Book
- Dosage forms
- suspension; tablet
- Routes
- oral
- Other brand names
- Atorvaliq
Sources: FDA Orange Book, FDA Purple Book, FDA drug shortages, FDA enforcement reports and CMS NADAC, read through QOPE. Not medical or legal advice.